Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Solana CompanyNASDAQ: HSDT
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow grows, but more slowly than its trailing trend
Q1 FY2026 free cash flow of $4.83M (cash outflow) rose 36.6% year over year, behind the +53.8% change in trailing-twelve-month free cash flow. Sequentially, it fell 21.8% from the prior quarter. Over 3 fiscal years it compounded at +62.3% a year.
Context
- Free cash flow amounted to 1018.7% of revenue in FY2025, down 1105.6 pp from a year earlier.
- Free cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +36.6% toward the trailing-twelve-month pace of +53.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (61.29M) USD
- Year-over-year change
- -454.9%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (61.29M) | -454.9% |
| FY2024 | 2024-12-31 | (11.05M) | -5.8% |
| FY2023 | 2023-12-31 | (10.45M) | +27.1% |
| FY2022 | 2022-12-31 | (14.33M) | -6.6% |
| FY2021 | 2021-12-31 | (13.44M) | — |
Free Cash Flow vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 free cash flow of $17.81M is the 8th largest of the 11 companies compared; the peer median is $27.27M.
- Its year-over-year change of +53.8% is the 4th highest of 11, against a peer median of +12.2%.
- Free cash flow amounts to 185.7% of revenue for HSDT, versus a peer median of 37.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $107.32M | +3.5% | +96.9% | 17365.9% | |
| LTM Mar 2026 | $82.9M | +151.2% | +10.0% | 57.2% | |
| LTM Dec 2025 | $47.63M | +21.0% | -3.8% | 365.8% | |
| LTM Mar 2026 | $38.97M | +44.5% | +14.8% | 206.5% | |
| LTM Mar 2026 | $34.25M | -64.6% | -32.6% | 29.1% | |
| LTM Mar 2026 | $20.3M | +57.7% | +113.8% | 14.3% | |
| LTM Mar 2026 | $20.3M | -42.8% | -17.0% | 45.2% | |
| LTM Mar 2026 | $17.81M | +53.8% | +62.3% | 185.7% | |
| LTM Mar 2026 | $10.24M | -51.5% | -28.4% | 2.9% | |
| LTM Mar 2026 | $10.23M | -14.4% | — | 14.3% | |
| LTM Mar 2026 | $5.86M | +937.6% | — | 13.2% | |
| Peer median (excluding HSDT) | $27.27M | +12.2% | +3.1% | 37.2% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Depreciation & Amortization | 374K | 306K | 162K | 60K | 680K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 1.63M | 2.52M | 9.25M |
| Change in Working Capital | 127K | (1.31M) | (311K) | (8K) | 230K |
| Accounts Receivables | 1K | (103K) | (291K) | (5K) | 0 |
| Inventory | (87K) | (111K) | 137K | (607K) | (85K) |
| Accounts Payables | 369K | (418K) | (103K) | 344K | 1.02M |
| Other Working Capital | (156K) | (674K) | (54K) | 260K | (702K) |
| Other Non-Cash Items | 4.24M | 762K | (3.05M) | (1.87M) | 14.22M |
| Operating Cash Flow | (13.39M) | (14.31M) | (10.42M) | (11.04M) | (16.51M) |
| Capital Expenditures | (54K) | (17K) | (29K) | (5K) | (44.78M) |
| Acquisitions (Net) | 0 | 6K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (426.53M) |
| Investing Cash Flow | (56K) | (11K) | (29K) | (5K) | (426.53M) |
| Debt Repayment | 0 | 0 | 0 | 0 | (680K) |
| Common Stock Issued | 21.13M | 17.87M | 1.08M | 6.95M | 467.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 3.99M | (17.11M) |
| Financing Cash Flow | 21.13M | 17.87M | 1.08M | 6.95M | 449.24M |
| Effect of Forex Changes | (8K) | (4K) | 1K | (2K) | 1K |
| Net Change in Cash | 7.67M | 3.54M | (9.37M) | (4.09M) | 6.19M |
| Free Cash Flow | (13.44M) | (14.33M) | (10.45M) | (11.05M) | (61.29M) |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.